Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge

Abstract

Recurrent nasopharyngeal carcinoma, which represents a small proportion of head-and-neck cancers, has a unique set of patho-clinical characteristics. The management of recurrent nasopharyngeal carcinoma remains a challenging clinical problem. Traditional treatments offer limited local control and survival benefits; more seriously, they frequently induce severe late complications. Recently, novel treatment techniques and strategies-including precision radiotherapy, endoscopic surgery or transoral robotic resection, third-generation chemotherapy regimens, and targeted therapies and immunotherapy-have provided new hope for patients with recurrent nasopharyngeal carcinoma. Some of these patients can potentially be cured with modern treatments. However, a lack of adequate evidence makes it difficult for clinicians to apply these powerful techniques and strategies. Individualized management guidelines, full evaluation of quality of life in these patients, and a further understanding of the mechanisms underlying recurrence are future directions for research into recurrent nasopharyngeal carcinoma.

Keywords: Nasopharyngeal carcinoma; biotherapy; chemotherapy; radiotherapy; recurrence; surgery.

Figures

FIGURE 1

Prognostic factors for recurrent nasopharyngeal carcinoma (rnpc). ebv = Epstein–Barr virus.

FIGURE 2

Treatment suggestion for recurrent nasopharyngeal carcinoma (rnpc).